Researchers at the University of Duisburg-Essen in Germany have pioneered an automated preparation technique that facilitates the large-scale manufacture of miniature lung organoids. These organoids incorporate microstructures identical to those of authentic lung cells. They serve as an effective platform for testing experimental medications, forecasting patient reactions to treatments like radiotherapy, and eliminate the need for animal-derived materials. This innovation holds the promise of revolutionizing the field of lung disease research.
